First Time Loading...

Infinity Pharmaceuticals Inc
NASDAQ:INFI

Watchlist Manager
Infinity Pharmaceuticals Inc Logo
Infinity Pharmaceuticals Inc
NASDAQ:INFI
Watchlist
Price: 0.0037 USD Market Closed
Updated: Apr 29, 2024

Wall Street
Price Targets

INFI Price Targets Summary
Infinity Pharmaceuticals Inc

There are no price targets for INFI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available

INFI Last Price Targets
Infinity Pharmaceuticals Inc

The latest public price target was made on May 23, 2022 by Unknown Analyst from Piper Sandler , who expects INFI stock to rise by 80 981% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Unknown Analyst
Piper Sandler
3 USD
Upside 80 981%
1 year ago
May 23, 2022
Piper Sandler Maintains Overweight on Infinity Pharmaceuticals, Lowers Price Target to $3
Benzinga
Unknown Analyst
Piper Sandler
Price Target 3 USD
Upside/Downside 80 981%
View Source
Infinity Pharmaceuticals Inc Competitors:
Price Targets
BIOA B
BioArctic AB
82% Upside
MRKR
Marker Therapeutics Inc
197% Upside
RYTM
Rhythm Pharmaceuticals Inc
55% Upside
IONS
Ionis Pharmaceuticals Inc
34% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
13% Upside
XOMA
XOMA Corp
185% Upside
3164
GenMont Biotech Inc
342% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
85% Upside

Revenue
Forecast

Revenue Estimate
Infinity Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Infinity Pharmaceuticals Inc's revenue is -40%. The projected CAGR for the next 2 years is 16%.

-40%
Past Growth
16%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Infinity Pharmaceuticals Inc

Operating Income forecast
is not available for
Infinity Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Infinity Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INFI's stock price target?
Not Available

INFI doesn't have any price targets made by Wall Street professionals.

What is Infinity Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Infinity Pharmaceuticals Inc's revenue is -40%. The projected CAGR for the next 2 years is 16%.